相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of Disease-Modifying Antirheumatic Drugs on Nonvertebral Fracture Risk in Rheumatoid Arthritis: A Population-Based Cohort Study
Seo Young Kim et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Inflammatory bone loss: pathogenesis and therapeutic intervention
Kurt Redlich et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Review article: the effects of antitumour necrosis factor-α on bone metabolism in inflammatory bowel disease
S. G. Veerappan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Adalimumab reduces hand bone loss in rheumatoid arthritis independent of clinical response: Subanalysis of the PREMIER study
Mari Hoff et al.
BMC MUSCULOSKELETAL DISORDERS (2011)
Initiation of Tumor Necrosis Factor-α Antagonists and the Risk of Hospitalization for Infection in Patients With Autoimmune Diseases
Carlos G. Grijalva et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
The change of bone mineral density according to treatment agents in patients with ankylosing spondylitis
Kwi Young Kang et al.
JOINT BONE SPINE (2011)
Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems
Lisa J. Herrinton et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2011)
Changes in Cotherapies After Initiation of Disease-Modifying Antirheumatic Drug Therapy in Patients With Rheumatoid Arthritis
Vivian K. Kawai et al.
ARTHRITIS CARE & RESEARCH (2011)
Bone, Inflammation, and Inflammatory Bowel Disease
Manasi Agrawal et al.
Current Osteoporosis Reports (2011)
Increased Fracture Risk in Patients with Rheumatic Disorders and Other Inflammatory Diseases - A Case-Control Study with 53,108 Patients with Fracture
Rudiger J. Weiss et al.
JOURNAL OF RHEUMATOLOGY (2010)
The multiple faces of autoimmune-mediated bone loss
Georg Schett et al.
NATURE REVIEWS ENDOCRINOLOGY (2010)
Risk of osteoporotic fracture in a large population-based cohort of patients with rheumatoid arthritis
Seo Young Kim et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
Masud
Clinical Interventions in Aging (2010)
Adalimumab therapy reduces hand bone loss in early rheumatoid arthritis: explorative analyses from the PREMIER study
M. y Hoff et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis
M. Gueler-Yueksel et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis
S. Visvanathan et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss
C. A. Wijbrandts et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Bone loss in patients with active early rheumatoid arthritis: infliximab and methotrexate compared with methotrexate treatment alone. Explorative analysis from a 12-month randomised, double-blind, placebo-controlled study
G. Haugeberg et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Factors Influencing Fracture Risk, T Score, and Management of Osteoporosis in Patients With Rheumatoid Arthritis in the Consortium of Rheumatology Researchers of North America (CORRONA) Registry
Kathryn A. Coulson et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2009)
Identification and Validation of Vertebral Compression Fractures Using Administrative Claims Data
Jeffrey R. Curtis et al.
MEDICAL CARE (2009)
Effect of Tumor Necrosis Factor Alpha Inhibition on Bone Density and Turnover Markers in Patients with Rheumatoid Arthritis and Spondyloarthropathy
Cheryl Barnabe et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2009)
Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: A longitudinal study
Changhai Ding et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis
F. Chopin et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Improvement of lumbar bone mass after infliximab therapy in Crohn's disease patients
Marina Mauro et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Fracture risk with intermittent high-dose oral glucocorticoid therapy
Frank de Vries et al.
ARTHRITIS AND RHEUMATISM (2007)
A 1-year case-control study in patients with rheumatoid arthritis indicates prevention of loss of bone mineral density in both responders and nonresponders to infliximab
Hubert Marotte et al.
ARTHRITIS RESEARCH & THERAPY (2007)
Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFκB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis
M. Vis et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis
T. P. van Staa et al.
ARTHRITIS AND RHEUMATISM (2006)
Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-α antibody:: a prospective open-label pilot study
U Lange et al.
RHEUMATOLOGY (2005)
Maintenance infliximab treatment is associated with improved bone mineral density in Crohn's disease
M Bernstein et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Clodronate reduces vertebral fracture risk in women with postmenopausal or secondary osteoporosis:: Results of a double-blind, placebo-controlled 3-year study
E McCloskey et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor α
F Allali et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
TNFa potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL
K Fuller et al.
ENDOCRINOLOGY (2002)
Threefold increased risk of hip fractures with rheumatoid arthritis in Central Finland
TM Huusko et al.
ANNALS OF THE RHEUMATIC DISEASES (2001)
Effect of risedronate on the risk of hip fracture in elderly women
MR McClung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Oral corticosteroids and fracture risk: relationship to daily and cumulative doses
TP van Staa et al.
RHEUMATOLOGY (2000)
Inhibition of osteoblast differentiation by tumor necrosis factor-α
L Gilbert et al.
ENDOCRINOLOGY (2000)
Tumor necrosis factor α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction
K Kobayashi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
